Article
Review: PrP 106‐126 – 25 years after
12 Jan 2019
Abstract excerpt
A quarter of a century ago, we proposed an innovative approach to study the pathogenesis of prion disease, one of the most intriguing biomedical problems that remains unresolved. The synthesis of a peptide homologous to residues 106-126 of the human prion protein (PrP106-126), a sequence present in the PrP amyloid protein of Gerstmann-Sträussler-Scheinker syndrome patients, provided a tractable tool for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
